Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-6.72%
+35.16%
+1.40%
+4.07%
+0.45%
KVUE
Kenvue
$15.80
Login to see Kenvue (KVUE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Trading below its fair value
Upgraded on attractively valued
Pays a reliable dividend
Risk Analysis
Earnings are forecast to decrease
Technical Indicators
Oversold
Chart
$18.87 (-16.27%)
$21.82 (-27.59%)
$23.35 (-32.33%)
$21.72 (-27.26%)
KVUE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
KVUE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Pays a reliable dividend
Future
Future
Trading below its fair value
Earnings are forecast to decrease
KVUE Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
KVUE Street view is unimpressive but have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayKVUE Earnings
The TTM reflects 12-month period, providing review of KVUE financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
What is KVUE current stock price?
What are KVUE stock strengths?
What risks are associated with KVUE stock?
When is KVUE next earnings report?
What is KVUE market cap and volume?
What is KVUE's current Stock IQ?
Should I buy KVUE stock right now?
Is KVUE a Strong Buy right now?
What does a 'Strong Buy' rating mean for KVUE?
What does a 'Strong Sell' rating mean for KVUE?
What factors influence KVUE's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-6.72%
+35.16%
+1.40%
+4.07%
+0.45%
KVUE
Kenvue
Current Price
$15.80
Stock Insights
Strengths
Trading below its fair value
Upgraded on attractively valued
Pays a reliable dividend
Risk Analysis
Earnings are forecast to decrease
Technical Indicators
Oversold
Login to unlock Kenvue (KVUE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$18.87 (-16.27%)
$21.82 (-27.59%)
$23.35 (-32.33%)
$21.72 (-27.26%)
KVUE Analysts Opinion
KVUE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Pays a reliable dividend
Future
Future
Trading below its fair value
Earnings are forecast to decrease
KVUE Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
KVUE Street view is unimpressive but have positive views on the near-term outlook
KVUE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayKVUE Earnings
The TTM data reflects the most recent 12-month period, providing overview of KVUE financial performance.
KVUE Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
KVUE Latest Analysis
Goldman Sachs Maintains Kenvue (KVUE) Neutral Recommendation. Fintel reports that on October 2 2025 Goldman Sachs maintained coverage of Kenvue (NYSE:KVUE) with a Neutral recommendation. Analyst Price Forecast Suggests 42.29% Upside
Today
Barclays Lowers PT on Kenvue (KVUE) to $17 From $20 Keeps an Equal Weight Rating. Kenvue Inc. (NYSE:KVUE) is one of the best most oversold large cap stocks so far in 2025. On October 1 Barclays lowered the firms price target on Kenvue Inc. (NYSE:KVUE) to $17 from $20 while keeping an Equal Weight rating on the shares. The firm told investors that it adjusted its models to reflect muted [….]
Today
Barclays Maintains Kenvue (KVUE) Equal-Weight Recommendation. Fintel reports that on October 1 2025 Barclays maintained coverage of Kenvue (NYSE:KVUE) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 41.17% Upside
Thu Oct 2, 2025
Cullen Trims KVUE Stake With $149.5M Share Sale. Key PointsSold 6565339 shares of Kenvue valued at approximately $149.46 million
Wed Oct 1, 2025
Should You Buy Kenvue Stock After Its 30% Plunge?. Key PointsA controversy over a possible link between Tylenol and autism is causing headaches for Kenvue.
Wed Oct 1, 2025
Rothschild & Co Upgrades Kenvue (KVUE). Fintel reports that on September 26 2025 Rothschild &. Co upgraded their outlook for Kenvue (NYSE:KVUE) from Neutral to Buy. Analyst Price Forecast Suggests 41.75% Upside
Fri Sep 26, 2025
Demystifying Kenvue: Insights From 11 Analyst Reviews. Kenvue (NYSE: ) underwent analysis by 11 analysts in the last quarter revealing a spectrum of viewpoints from ish to bearish.In the table below you'.ll find a summary of their recent ratings revealing the shifting sentiments over the past 30 days and comparing them to the previous months.3170010000003001010011300Analysts'. evaluations of 12-month price targets offer additional insights showcasing an average target of $22.64 with a hi
Fri Sep 26, 2025
Jim Cramer Discusses Kenvue Inc. (KVUE) & Legal Issues. We recently published 14 Stocks Jim Cramer Discussed Including His 2 Top Quantum Computing Stocks. Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer recently discussed. Kenvue Inc. (NYSE:KVUE) has been in the news lately after President Trump asserted that taking Tylenol can increase autism in unborn children. The firms shares have lost 22% [….]
Fri Sep 26, 2025
Rothschild upgrades Kenvue after Tylenol scare wipes $10 billion in market value.
Fri Sep 26, 2025
Kenvue Surges Over 2% Pre-Market Despite Trump Administrations Autism Warning. ) saw its stock rise by 2.61% to $17.69 in pre-market trading on Wednesday despite concerns stirred by President potentially being linked to autism. Check out the current price of .According to Benzinga Pro data the consumer healthcare company closed the previous trading day at $17.24 marking a 1.59% increase from the day before.During a press conference on Monday President Trump recommended that pregnant women steer
Wed Sep 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
KVUE Stock trends
KVUE Stock performance
KVUE Stock analysis
KVUE investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings